U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Genomic Health, Inc. (GHDX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
30.98+0.13 (+0.42%)
At close: 4:00PM EDT
People also watch
FMILMNXQGENSGENACOR
Full screen
Previous Close30.85
Open31.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range30.74 - 31.06
52 Week Range26.37 - 33.97
Volume79,487
Avg. Volume97,237
Market Cap1.07B
Beta0.47
PE Ratio (TTM)-206.53
EPS (TTM)-0.15
Earnings DateOct 30, 2017 - Nov 3, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.10
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Genomic Health, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Genomic Health, Inc. Here are 5 ETFs with the largest exposure to GHDX-US. Comparing the performance and risk of Genomic Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Genomic Health Ties up With Biocartis, Boosts Oncotype DX
    Zacks9 days ago

    Genomic Health Ties up With Biocartis, Boosts Oncotype DX

    Genomic Health's (GHDX) agreement with Biocartis will provide Genomic Health rights to develop and commercialize its Oncotype DX Breast Recurrence Score test on the Idylla platform.

  • Genomic Health, Inc. :GHDX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cube10 days ago

    Genomic Health, Inc. :GHDX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Genomic Health, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Genomic Health, Inc. – Quest Diagnostics Incorporated, Trovagene, Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Foundation Medicine, Inc., Biocept, Inc., QIAGEN NV, NeoGenomics, Inc. and Exact ... Read more (Read more...)